17-63704449-G-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_001003787.4(STRADA):​c.992C>A​(p.Thr331Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000651 in 1,612,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T331I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000066 ( 0 hom. )

Consequence

STRADA
NM_001003787.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.122

Publications

1 publications found
Variant links:
Genes affected
STRADA (HGNC:30172): (STE20 related adaptor alpha) The protein encoded by this gene contains a STE20-like kinase domain, but lacks several residues that are critical for catalytic activity, so it is termed a 'pseudokinase'. The protein forms a heterotrimeric complex with serine/threonine kinase 11 (STK11, also known as LKB1) and the scaffolding protein calcium binding protein 39 (CAB39, also known as MO25). The protein activates STK11 leading to the phosphorylation of both proteins and excluding STK11 from the nucleus. The protein is necessary for STK11-induced G1 cell cycle arrest. A mutation in this gene has been shown to result in polyhydramnios, megalencephaly, and symptomatic epilepsy (PMSE) syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their full-length nature is not known. [provided by RefSeq, Sep 2009]
STRADA Gene-Disease associations (from GenCC):
  • polyhydramnios, megalencephaly, and symptomatic epilepsy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012217611).
BP6
Variant 17-63704449-G-T is Benign according to our data. Variant chr17-63704449-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 573381.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000525 (8/152274) while in subpopulation SAS AF = 0.00104 (5/4826). AF 95% confidence interval is 0.000408. There are 0 homozygotes in GnomAd4. There are 7 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001003787.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STRADA
NM_001003787.4
MANE Select
c.992C>Ap.Thr331Asn
missense
Exon 11 of 13NP_001003787.1Q7RTN6-1
STRADA
NM_001363786.1
c.968C>Ap.Thr323Asn
missense
Exon 11 of 13NP_001350715.1
STRADA
NM_001363787.1
c.905C>Ap.Thr302Asn
missense
Exon 9 of 11NP_001350716.1A0A1W2PPJ9

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STRADA
ENST00000336174.12
TSL:1 MANE Select
c.992C>Ap.Thr331Asn
missense
Exon 11 of 13ENSP00000336655.6Q7RTN6-1
STRADA
ENST00000375840.9
TSL:1
c.818C>Ap.Thr273Asn
missense
Exon 10 of 12ENSP00000365000.4Q7RTN6-5
STRADA
ENST00000392950.9
TSL:1
c.881C>Ap.Thr294Asn
missense
Exon 9 of 9ENSP00000376677.4Q7RTN6-2

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152156
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000117
AC:
29
AN:
248820
AF XY:
0.000178
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000356
Gnomad OTH exome
AF:
0.000330
GnomAD4 exome
AF:
0.0000664
AC:
97
AN:
1460722
Hom.:
0
Cov.:
45
AF XY:
0.0000895
AC XY:
65
AN XY:
726650
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000939
AC:
81
AN:
86222
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52478
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000989
AC:
11
AN:
1111874
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000525
AC:
8
AN:
152274
Hom.:
0
Cov.:
31
AF XY:
0.0000940
AC XY:
7
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41570
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000226
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.000157
AC:
19
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
Polyhydramnios, megalencephaly, and symptomatic epilepsy (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
10
DANN
Benign
0.82
DEOGEN2
Benign
0.044
T
Eigen
Benign
-0.87
Eigen_PC
Benign
-0.73
FATHMM_MKL
Benign
0.47
N
LIST_S2
Benign
0.76
T
M_CAP
Benign
0.0061
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.43
N
PhyloP100
0.12
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.050
N
REVEL
Benign
0.037
Sift
Benign
0.38
T
Sift4G
Benign
0.45
T
Polyphen
0.0
B
Vest4
0.21
MVP
0.23
MPC
0.49
ClinPred
0.0072
T
GERP RS
0.36
PromoterAI
0.0054
Neutral
Varity_R
0.045
gMVP
0.19
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs539671529; hg19: chr17-61781809; API